NYSE:ABBVBiotechs
Is AbbVie (ABBV) Still Attractive After A 21.5% One Year Share Price Gain?
If you are wondering whether AbbVie stock still offers value after a strong run, it is important to see how different valuation methods line up against the current share price.
The stock recently closed at US$215.40, with returns of 1.5% over the past week, 9.1% over the past month, and 21.5% over the past year, while year to date it is down 6.1%.
Recent coverage has focused on AbbVie's position in the large cap pharmaceuticals and biotech space and how investors weigh long term drug...